Fundamentals Data provided by Morningstar.Data provided by Morningstar.
52 Week Range
Avg. Volume (1 month)
as at 24 Feb 3:44pm
Should you invest $1,000 in right now?
Before you consider , you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.
The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of August 16th 2021
4 ‘defensive growth’ ASX shares to buy in turbulent times: Wilsons
Small Cap Shares
5 profitable small-cap ASX shares to buy right now: Wilsons
Top broker picks 6 ASX 200 shares with earnings surprise potential
Share Market News
2 ASX shares that top analysts are loving right now
Share Market News
Goldman Sachs just added this ASX healthcare share to its conviction buy list
The HCW (ASX:HCW) share price has gained 15% since the REIT’s IPO
Motley Fool Media
Fortescue’s big fall, job ad numbers disappoint and rates in focus. Scott Phillips on Nine’s Late News
|30 Mar 2022||$0.0225||0.00%||Interim||20 May 2022|
|30 Dec 2021||$0.0300||0.00%||Interim||25 Feb 2022|
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
|Date||Announcement||Price Sensitive?||Time||No. of Pages||File Size|
HealthCo Healthcare and Wellness REIT are owning and managing a portfolio of commercial health and wellness real estate assets.
|17 May 2022||$1.69||$-0.02||-1.17%||278,021||$1.67||$1.73||$1.67|
|16 May 2022||$1.71||$0.03||1.79%||398,527||$1.68||$1.72||$1.67|
|13 May 2022||$1.68||$0.03||1.82%||490,598||$1.70||$1.72||$1.62|
|12 May 2022||$1.65||$-0.02||-1.20%||429,474||$1.68||$1.68||$1.62|
|11 May 2022||$1.67||$0.02||1.21%||494,576||$1.64||$1.73||$1.61|
|10 May 2022||$1.65||$-0.07||-4.07%||604,801||$1.70||$1.70||$1.61|
|09 May 2022||$1.72||$-0.06||-3.37%||463,605||$1.78||$1.78||$1.70|
|06 May 2022||$1.78||$-0.07||-3.78%||645,841||$1.82||$1.83||$1.77|
|05 May 2022||$1.85||$-0.09||-4.65%||696,132||$1.93||$1.95||$1.85|
|04 May 2022||$1.94||$0.00||0.00%||1,012,342||$1.92||$1.99||$1.91|
|03 May 2022||$1.94||$0.00||0.00%||311,066||$1.93||$1.94||$1.92|
|02 May 2022||$1.94||$-0.03||-1.52%||443,280||$1.94||$1.97||$1.93|
|29 Apr 2022||$1.97||$-0.01||-0.51%||881,506||$1.95||$1.98||$1.95|
|28 Apr 2022||$1.98||$0.05||2.59%||488,120||$1.94||$1.99||$1.91|
|27 Apr 2022||$1.93||$0.01||0.52%||242,675||$1.92||$1.94||$1.89|
|26 Apr 2022||$1.92||$-0.02||-1.03%||499,208||$1.93||$1.94||$1.88|
|22 Apr 2022||$1.94||$-0.01||-0.51%||280,202||$1.93||$1.96||$1.93|
|21 Apr 2022||$1.95||$0.07||3.72%||543,642||$1.90||$1.98||$1.87|
|20 Apr 2022||$1.88||$-0.02||-1.05%||630,514||$1.89||$1.92||$1.88|
|05 May 2022||David Di Pilla||Buy||58||$109,775|| |
|04 May 2022||David Di Pilla||Buy||1||$2,039,589|| |
|03 May 2022||David Di Pilla||Buy||165||$320,232|| |
|02 May 2022||David Di Pilla||Buy||241||$468,651|| |
|29 Apr 2022||David Di Pilla||Buy||401||$787,960|| |
|28 Apr 2022||David Di Pilla||Buy||192||$375,311|| |
|10 Mar 2022||David Di Pilla||Buy||509||$993,537|| |
|03 Mar 2022||David Di Pilla||Buy||347||$687,568|| |
|02 Mar 2022||David Di Pilla||Buy||70||$133,784|| |
|01 Mar 2022||David Di Pilla||Buy||93||$178,134|| |
|Dr Christopher Graham Roberts||Non-Executive Director||Aug 2021|| |
Dr Roberts has worked in the medical device industry for over 40 years in a number of senior management positions. He was former CEO of Cochlear from 2004 to 2015 and member of the Cochlear Foundation Board. He was founding director and Executive Vice President of ResMed from 1992 to 2003, and a director until November 2017. He has served as Chair of OncoSil Medical Limited, Chair of TEDI London and non-executive director of Clarity Pharmaceuticals Limited and Atmo Biosciences Pty Ltd. He was also a former Chair of Research Australia (2004 to 2010).
|Ms Stephanie Lai||Non-Executive Director||Aug 2021|| |
Ms Lai has over 20 years' experience as a Chartered Accountant and a former M&A partner of Deloitte and KPMG. She also has experience providing due diligence and advisory services, including forecast reviews to listed entities, sovereign wealth funds, wealth managers and private equity. She is currently serves as independent Non-Executive Director of HMC Funds Management Limited (responsible entity of HomeCo Daily Needs REIT), Superloop and Future Generation Investment Company. She is a member of the Association of Corporate Counsel Australia. She is also Chair of Risk Committee of HCW.
|Mr David Anthony Di Pilla||Non-Executive Director||Jul 2021|| |
Mr Di Pilla has over 20 years of experience in investment banking. He is currently Managing Director and Chief Executive Officer of Home Consortium, and Non-Executive Director of HMC Funds Management Limited (responsible entity of HomeCo Daily Needs REIT). He was a founder, director and shareholder of Aurrum. He was a former strategic advisor and Director to operating subsidiaries of the Tenix Group of Companies from 2014 to 2016. From 2004 to 2015, David was Managing Director and Senior Adviser at UBS, Australia and during this time he advised some of Australia's corporations on mergers and acquisitions, debt and equity capital market transactions.
|Hon Kelly Megan O'Dwyer||Non-Executive Director||Aug 2021|| |
The Hon O'Dwyer has experience in across a range of sectors including funds management, superannuation, workplace relations, foreign investment, law and banking. She is currently serves as independent Non-Executive Director of Home Consortium, EQT Holdings Limited and Barrenjoey Capital Partners Group Holdings Pty Ltd. She has served in the Australian Parliament as a Senior Cabinet Minister holding a number of economic portfolios including Minister for Jobs and Industrial Relations; Minister for Revenue and Financial Services; Minister for Small Business; and Assistant Treasurer. She has also served as Minister for Women; as well as Minister Assisting the Prime Minister with the Public Service. She was former member of the Cabinet's Budget Committee (the Expenditure Review Committee). Prior to entering Parliament, he has worked in law, government and finance.
|Mr Joseph Carrozzi||Non-Executive ChairmanNon-Executive Director||Aug 2021|| |
Mr Carrozzi is a partner in the Big 4 professional services firms for over 20 years, commencing with Tax & Legal Leader at Andersens, Regional Managing Partner at EY and then joining PwC in 2005 as National Managing Partner, Markets and Sydney Office. He has served as Chair of the Centenary Institute for Medical Research, Chair of Sydney Harbour Federation Trust and Deputy Chair of the NSW Institute of Sport. He has also served as Governor on the board of Western Sydney University and Board member of Football Australia. He is also member of Risk Committee of HCW.
|Ms Natalie Jane Meyenn||Non-Executive Director||Aug 2021|| |
Ms Meyenn has over 25 years' experience in financial services and investing globally. Previously, she held the roles of CIO and Chair of the Investment Committee for MLC Private Equity. She has worked in Investment Banking (M&A, capital markets and public finance) in New York and Sydney for many years and spent time at the World Bank working in Asia, Africa and the Pacific Islands on microfinance, project finance and climate change impact mitigation strategies. She has also served as director and/or shareholder for a small number of asset management and investment businesses in Europe and Australia, including a carbon neutral asset management platform in Australia. She is also proposed director of the fund manager of the Unlisted Fund. She is also member of Risk Committee of HCW.
|Mr Andrew Selim||Company SecretaryGeneral Counsel|| |
|Andrew Selim||Company SecretaryGeneral Counsel|| |
|Home Consortium Developments Limited||65,000,010||19.99%|
|HSBC Custody Nominees (Australia) Limited||47,434,528||14.59%|
|J P Morgan Nominees Australia Pty Limited||20,259,926||6.23%|
|National Nominees Limited||19,098,690||5.87%|
|Citicorp Nominees Pty Limited||17,237,957||5.30%|
|HSBC Custody Nominees (Australia) Limited A/C 2||12,569,740||3.87%|
|UBS Nominees Pty Ltd||9,260,226||2.85%|
|BNP Paribas Noms Pty Ltd (Drp)||4,561,901||1.40%|
|Netwealth Investments Limited (Wrap Services A/C)||4,441,631||1.37%|
|BNP Paribas Nominees Pty Ltd (Agency Lending Drp A/C)||3,220,828||0.99%|
|Warbont Nominees Pty Ltd (Unpaid Entrepot A/C)||2,945,434||0.91%|
|Custodial Services Limited (Beneficiaries Holding A/C)||1,650,000||0.51%|
|Seymour Group Pty Ltd||1,650,000||0.51%|
|Bridgebox Pty Limited (Bridgebox A/C)||1,500,000||0.46%|
|Sword Equity Investments Pty Ltd||1,375,000||0.42%|
|Netwealth Investments Limited (Super Services A/C)||1,321,487||0.41%|
|Goat Properties Pty Ltd||1,250,000||0.38%|
|BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd (Drp A/C)||1,215,306||0.37%|
|Premium Capital (Aust) Pty Ltd||1,082,000||0.33%|
|BNP Paribas Nominees Pty Ltd (Pitcher Partners Drp)||996,010||0.31%|
|Friday Investments Pty Limited (Goldburg Family Account)||800,000||0.25%|